Journal Information

Statistics

Follow this link to access the full text of the article

SAFETY AND EFFICACY FINDINGS OF A PHASE 1B/2 STUDY OF NANATINOSTAT PLUS VALGANCICLOVIR FOR TREATMENT OF RELAPSED/REFRACTORY EPSTEIN-BARR VIRUS-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA
M Capraa, P Scheinbergb, J Pereirac, B Haverkosd, S Spruille, D Stricklandf, P Porcug
a Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil
b Division of Hematology, A Beneficência Portuguesa de São Paulo (BP), São Paulo, Brazil
c Division of Hematology, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), São Paulo, Brazil
d Division of Hematology, University of Colorado, Denver, United States
e Applied Statistics and Consulting, Spruce Pine, United States
f Viracta Therapeutics, Inc., Cardiff, United States
g Division of Hematologic Malignancies and Hematopoetic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, United States
Read
273
Times
was read the article
141
Total PDF
132
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 26 17 43
2024 April 36 9 45
2024 March 22 20 42
2024 February 14 23 37
2024 January 14 21 35
2023 December 12 23 35
2023 November 6 16 22
2023 October 2 12 14

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy